Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805688 · ClinicalTrials.gov registry record
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT00805688: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00805688 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00805688 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer. Researchers will study the possible reason for these symptoms by drawing blood samples and comparing the test results to the symptoms you experience. The study will also use a special telephone system for measuring the symptoms of participants during and after therapy. Your level of physical activity will also be studied using a pedometer and study diary.
Interventions
- BEHAVIORAL Questionnaires
- DEVICE Pedometer
- PROCEDURE Blood Draws
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-11-12 |
| Est. Completion | 2018-02-27 |
What the finished NCT00805688 record still lists
NCT00805688 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT00805688 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00805688 about?
NCT00805688 is a clinical study titled "Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer". The goal of this clinical research study is to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer. Researchers will study the possible reason for these symptoms by drawing blood samples and comparing the test results to the symptoms you experien...
What is the current status of trial NCT00805688?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2008-11-12. Estimated completion is 2018-02-27.
What interventions are being tested in trial NCT00805688?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Pedometer (DEVICE), Blood Draws (PROCEDURE).
Who is sponsoring clinical trial NCT00805688?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI